Latest filing published 23 Sept 2026 for Hims & Hers Health, Inc., €61k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Oluyemi Okupe in Hims & Hers Health, Inc., where the filings describe the role as finance chief. Between 19 May 2022 and 1 October 2026, the trades on record add up to 84 filings.
In open-market terms, that means 1 purchase worth €25k on one side and 29 sales worth €10.1M on the other. Netting one side against the other leaves €10.1M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants and 51 option exercises. Since January 2026: no purchases and 12 sales on the market.
The newest entry dates from 2 October 2026: an open-market sale of €52k, in Hims & Hers Health, Inc. The latest purchase dates back some time: it was published 1,612 days ago, on 23 May 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 81 declarations